As the global obesity crisis intensifies, Taiwan-based TCI Co. Ltd., a leader in the development of health and cosmetic products for over 40 years, has introduced a breakthrough in weight management with its new GLP-1 formula. The cutting-edge blend of plant extracts, probiotics, and prebiotics is designed to tackle obesity naturally by supporting weight loss and improving metabolic health.
The rising concern over obesity is staggering. According to the World Health Organisation (WHO), over one billion people globally were classified as obese in 2022, accounting for around one-eighth of the world’s population. This trend shows no signs of slowing down, with the World Obesity Federation predicting the economic cost of obesity will surpass $4 trillion by 2035. Meanwhile, The Economist forecasts that the market for weight loss and obesity treatments will expand to $150 billion by the early 2030s, with GLP-1 analogues becoming as commonly prescribed as medications for high blood pressure or cholesterol.
TCI’s Innovative GLP-1 Formula
TCI’s GLP-1 (Glucagon-Like Peptide-1) formula represents a breakthrough in the field of natural weight management. It is based on extensive research and development, including in-vitro studies and human trials, which have demonstrated the formula’s ability to aid in weight loss, stabilise blood sugar levels, and enhance fat metabolism. The formula works by stimulating the body’s natural GLP-1 secretion, which helps regulate appetite, increase fat burning, and stabilise glucose levels.
GLP-1 is a hormone secreted by intestinal L-cells in response to food intake. It plays a crucial role in controlling insulin secretion, suppressing the release of glucagon, reducing appetite, and slowing gastric emptying, all of which are key factors in managing hunger and promoting fat loss. TCI’s GLP-1 formula harnesses these natural processes, using plant-based ingredients to enhance the body’s metabolic functions and support healthy weight management.
Vincent Lin, Chairman of TCI, highlighted the company’s commitment to scientific innovation:
“At TCI, we develop high-performance supplements based on scientifically proven data, ensuring our clients’ products enhance consumer health and quality of life.”
Proven Results in Weight Loss and Health Improvements
The effectiveness of TCI’s GLP-1 formula has been demonstrated through internal human trials. Participants experienced an average weight loss of 4.9kg over a two-month period, reflecting the formula’s potential to promote healthier lifestyles. TCI has made the formula available in various formats, including liquid, powder sachets, and tablets, making it accessible and convenient for consumers.
One of the key findings from TCI’s trials was the formula’s ability to significantly increase GLP-1 concentration in the body. A controlled trial revealed that participants who took the GLP-1 formula showed a 10.3% increase in GLP-1 levels within an hour, compared to those who did not. This boost in GLP-1 helped stabilise hunger and supported healthy weight loss.
In another study, the formula’s ability to regulate post-meal blood sugar levels was highlighted. Participants who consumed breakfast alongside the GLP-1 formula experienced a remarkable 97% reduction in blood sugar spikes, a significant improvement that could help prevent long-term health issues related to high glucose levels.
Additionally, the GLP-1 formula was found to improve key health markers beyond weight loss. A four-week trial showed that participants using the formula had a 4.2% reduction in total cholesterol levels, a 2.93% increase in HDL (the “good” cholesterol), and a 2.71% decrease in LDL (the “bad” cholesterol). These improvements lower the risk of cardiovascular disease while promoting overall health.
Addressing the Global Obesity Crisis
The development of TCI’s GLP-1 formula comes at a critical time, as the world continues to grapple with rising obesity rates. The natural weight loss industry is evolving, with consumers seeking safer, more sustainable alternatives to traditional weight loss medications. By offering a plant-based solution backed by rigorous scientific research, TCI aims to meet this growing demand while setting new standards in the health and nutrition industry.
TCI has already begun fast-tracking its GLP-1 formula for international markets through partnerships with global clients. The company’s mission is clear: to deliver natural, effective weight management solutions that not only improve consumers’ lives but also lead the way in the next generation of health and wellness products.
As the global market for weight loss solutions continues to grow, TCI’s innovative GLP-1 formula positions the company at the forefront of the health and nutrition sector. By addressing the root causes of obesity and offering a natural, scientifically validated approach to weight management, TCI is paving the way for a healthier future for consumers worldwide.
For more information, visit TCI’s website: https://www.tci-bio.com.
